Pfizer Inc.

History

Year	Detail
1849	Charles Pfizer and Charles Erhart founded Charles Pfizer and company in a red brick building in Brooklyn, New York.
1868	Pfizer moved its headquarters to Manhattan.
1882	Pfizer opens offices and a warehouse in Chicago, Illinois.
1936	Dr Richard Pasternack developed a fermentation-free method for producing ascorbic acid, which is Vitamin C. Pfizer became the world's leading producer of Vitamin C.
1944	Pfizer successfully mass-produced penicillin and became the largest producer of the "miracle drug."
1950	Terramycin, an antibiotic, became the first pharmaceutical sold in the U.S. under the Pfizer label.
1951	Pfizer operates in Belgium, Brazil, Canada, Cuba, England, Mexico, Panama, and Puerto Rico.
1952	Pfizer established an agricultural division dedicated to offering solutions to animal health problems.
1953	After the acquisition, J.B. Roerig and Company became a division of Pfizer.
1955	A fermentation plant opens in England. Pfizer partners with Japan's Taito to manufacture and distribute antibiotics.
1958	New Pfizer pharmaceutical plants begin production in Mexico, Italy, and Turkey.
1960	The Company consolidated its medical research laboratory operations in Groton, Connecticut.
1961	Pfizer established headquarters in midtown Manhattan.
1967	The company launched Vibramycin (doxycycline hyclate).
1971	Pfizer acquired Mack Illertissen, a pharmaceutical, chemical, and consumer product manufacturer.
1976	Pfizer introduced Minipress (prazosin HCI) in the U.S. to control high blood pressure.
1980	Feldene (piroxicam) became Pfizer's first product to reach a billion U.S. dollars in sales.
1984	The company launched Glucotrol (glipizide) for diabetes.
1986	Pfizer introduced Unasyn (ampicillin-sulbactam), an injectable antibiotic.
1986	The company remaned its Agricultural Division into the Animal Health Division.
1989	Pfizer launched Procardia XL (nifedipine) extended-release tablets, a medication for angina and hypertension.
1992	Pfizer launched three new medicines: Zoloft (sertraline hydrochloride) for the treatment of depression, Norvasc (amlodipine besylate) for the control of angina and hypertension, and Zithromax (azithromycin) for respiratory and skin infections.
1995	The Animal Health division of Pfizer purchased SmithKline Beecham's animal health business.
1998	Pfizer's launched Viagra (sildenafil citrate) drug, a treatment for erectile dysfunction.
2000	Pfizer and Warner-Lambert merged to form the new Pfizer.
2004	The company launched Caduet (amlodipine besylate and atorvastatin calcium), a pill that treats high blood pressure and cholesterol.
2005	Pfizer launched Lyrica (pregabalin), the first treatment approved by the U.S. Food and Drug Administration for the treatment of partial onset seizures in adults with epilepsy.
2006	The company launched Sutent (sunitinib malate), an oral multikinase inhibitor, to treat patients with metastatic renal cell carcinoma (mRCC), advanced kidney cancer, and gastrointestinal stromal tumors.
2007	Pfizer launched Selzentry (maraviroc) tablets, oral HIV medicines.
2009	Pfizer acquired Wyeth, a drug-making company, for approximately $68 billion.
2010	Pfizer announced a diversified R&D platform named Pfizer Worldwide Research and Development.
2011	Pfizer Completed Sale of Capsugel Business to Kohlberg Kravis Roberts & Co. L.P. (KKR).
2014	Pfizer acquires Baxter International Inc.'s portfolio of marketed vaccines for $635 million.
2015	Pfizer acquired Hospira, a US-based provider of injectable drugs and infusion technologies, for approximately $17bn.
2016	Watson Health and Pfizer announced a collaboration; the company utilized IBM Watson for Drug Discovery.
2017	Pfizer and Corning Inc. collaborated and launched Corning Valor Glass. Valor Glass packaging solution has been designed to enable chemical durability and resist breakage, damage, and particulate contamination.
2020-21	Pfizer developed a vaccine and treatment in response to the COVID-19 pandemic.
2022	The company acquired several companies, including Arena Pharmaceuticals, ReViral, Biohaven Pharmaceutical Holding Company Ltd., and Global Blood Therapeutics, Inc.